These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 200123)

  • 21. [Resistance to viral-induced tumors in the chicken].
    Coudert F; Chausse AM; Quere P; Thoraval P; Dambrine G
    Ann Rech Vet; 1992; 23(3):322-5. PubMed ID: 1329605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of Marek's disease using 3 vaccines in chickens belonging to different genetic varieties of meat producers].
    Picault JP; Guittet M; Bennejean G; Goater E
    Dev Biol Stand; 1982; 52():447-53. PubMed ID: 6299854
    [No Abstract]   [Full Text] [Related]  

  • 23. The simple chicken major histocompatibility complex: life and death in the face of pathogens and vaccines.
    Kaufman J
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1077-84. PubMed ID: 11186309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histocompatibility antigen(s) linked to Rfp-Y (Mhc-like) genes in the chicken.
    Pharr GT; Gwynn AV; Bacon LD
    Immunogenetics; 1996; 45(1):52-8. PubMed ID: 8881037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MHC of the chicken, genomic structure, gene products, and resistance to oncogenic DNA and RNA viruses.
    Simonsen M
    Vet Immunol Immunopathol; 1987 Dec; 17(1-4):243-53. PubMed ID: 2829414
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of humoral immunity in chickens prevents transient paralysis caused by a herpesvirus.
    Parker MA; Schierman LW
    J Immunol; 1983 May; 130(5):2000-1. PubMed ID: 6300237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of the major histocompatibility complex of the chicken.
    Hála K; Vilhelmová M; Hartmanová J
    Adv Exp Med Biol; 1977; 88():227-32. PubMed ID: 21544
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune response and disease resistance in chickens. II. Marek's disease and immune response to GAT.
    Pevzner IY; Kujdych I; Nordskog AW
    Poult Sci; 1981 May; 60(5):927-32. PubMed ID: 7267547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies to infectious bursal disease virus serotypes I and II in 75 Ohio chicken flocks.
    Jackwood DJ; Saif YM
    Avian Dis; 1983; 27(3):850-4. PubMed ID: 6314983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic analysis of T cells and antibody production in chickens infected with Marek's disease virus.
    Yamamoto H; Hattori M; Ohashi K; Sugimoto C; Onuma M
    J Vet Med Sci; 1995 Oct; 57(5):945-6. PubMed ID: 8593309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marek's disease tumor-associated surface antigen (MATSA) in resistant versus susceptible chickens.
    Murthy KK; Calnek BW
    Avian Dis; 1979; 23(4):831-7. PubMed ID: 232656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative response of chicken T- and B-lymphocytes to mitogens.
    Lee LF
    Prog Clin Biol Res; 1984; 161():41-52. PubMed ID: 6435130
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effective and time efficient measurement of CD4, CD8, major histocompatibility complex Class II, and macrophage antigen expression in the lungs of chickens.
    Fletcher OJ; Tan X; Cortes L; Gimeno I
    Vet Immunol Immunopathol; 2012 May; 146(3-4):225-36. PubMed ID: 22484239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.
    Chappell P; Meziane el K; Harrison M; Magiera Ł; Hermann C; Mears L; Wrobel AG; Durant C; Nielsen LL; Buus S; Ternette N; Mwangi W; Butter C; Nair V; Ahyee T; Duggleby R; Madrigal A; Roversi P; Lea SM; Kaufman J
    Elife; 2015 Apr; 4():e05345. PubMed ID: 25860507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV.
    Omar AR; Schat KA
    Immunology; 1997 Apr; 90(4):579-85. PubMed ID: 9176112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precipitating antibody development in chicks experimentally infected with herpes virus of turkey and Marek's disease virus.
    Rana UV; Negi SK
    J Commun Dis; 1986 Mar; 18(1):13-6. PubMed ID: 3018071
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of cytotoxicity-associated genes in Marek's disease virus-infected chickens.
    Sarson AJ; Abdul-Careem MF; Read LR; Brisbin JT; Sharif S
    Viral Immunol; 2008 Jun; 21(2):267-72. PubMed ID: 18570592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marek's disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression.
    Gimeno IM; Witter RL; Hunt HD; Lee LF; Reddy SM; Neumann U
    Vet Pathol; 2001 Sep; 38(5):491-503. PubMed ID: 11572556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.